FDA approves 1st drug to delay the onset of Type 1 diabetes

The drug, called Tzield, is the first-ever FDA approved treatment intended to delay the onset of type 1 diabetes in adults and children ages 8 and up.

Powered by NewsAPI , in News on .

news image
The drug, called Tzield, is the first-ever FDA approved treatment intended to delay the onset of type 1 diabetes in adults and children ages 8 and up.
Read More